SELLAS Life Sciences Group, Inc. ( SLS) - Stock Earnings
SLS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
SLS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.7 million USD | — USD |
| 2026Q1 | -8.4 million USD | — USD |
| 2026Q2 | -9.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SLS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.3 million USD | — USD |
| 2024 | -30.9 million USD | — USD |
| 2025 | -26.9 million USD | — USD |
| 2026 Est. | — | — |
SLS
Price: $12.78
52 week price:
Earnings Per Share: -0.22 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 183300
Ebitda: -4.4 millionMarket Capitalization: 2.5 billion